WO2011007552A1 - Bad breath-removing agent - Google Patents

Bad breath-removing agent Download PDF

Info

Publication number
WO2011007552A1
WO2011007552A1 PCT/JP2010/004531 JP2010004531W WO2011007552A1 WO 2011007552 A1 WO2011007552 A1 WO 2011007552A1 JP 2010004531 W JP2010004531 W JP 2010004531W WO 2011007552 A1 WO2011007552 A1 WO 2011007552A1
Authority
WO
WIPO (PCT)
Prior art keywords
sugar alcohol
bad breath
lactitol
maltitol
active ingredient
Prior art date
Application number
PCT/JP2010/004531
Other languages
French (fr)
Japanese (ja)
Inventor
児玉悠史
樋口裕明
成瀬敦
桜井孝治
Original Assignee
株式会社ロッテ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 株式会社ロッテ filed Critical 株式会社ロッテ
Priority to CN2010800297111A priority Critical patent/CN102470114A/en
Publication of WO2011007552A1 publication Critical patent/WO2011007552A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention relates to a bad breath removing agent characterized by suppressing production of volatile sulfur compounds by sugar alcohol.
  • VSC volatile sulfur compounds
  • methyl mercaptan volatile nitrogen compounds
  • dimethyl sulfide either alone or in combination.
  • Other substances are detected in exhaled breath, but it is rare to detect concentrations above the human odor threshold.
  • VSC the main cause of bad breath
  • HSC hydrogen sulfide is produced from cysteine due to the involvement of bacterial cystathionine- ⁇ -syntase and cystathionine- ⁇ -lyase
  • methyl mercaptan is produced from methionine due to the involvement of L-methionine- ⁇ -lyase.
  • VSC is not only a malodorous substance but also has a strong biotoxicity. It has been reported that VSC enhances permeability of mucous membranes having a barrier function, promotes collagen synthesis inhibition of fibroblasts and damage of epithelial basement membrane, and inhibits synthesis. In particular, in experiments using human leukocytes, hydrogen sulfide increases the production of active oxygen, while strongly inhibiting superoxide dismutase (SOD), suggesting the possibility that VSC has carcinogenicity. Therefore, suppressing bad breath becomes important in maintaining oral health.
  • SOD superoxide dismutase
  • Patent Document 1 relates to the invention of chewing gum.
  • a composition containing calcium dihydrogen phosphate and calcium glycerophosphate is kneaded with a gum base to produce a chewing gum, which is chewed, and has an immediate effect and sustainability of a bad breath effect.
  • Panelists made a sensory evaluation.
  • As a result in the case of 60% xylitol blended gum, 10/10 people recognized immediate effect and 7/10 people recognized durability.
  • xylitol was replaced with 60% sucrose, 5/10 people recognized immediate effect and 3/10 people recognized sustainability.
  • the effect of removing bad breath is improved by containing one or more sugar alcohols from the group consisting of xylitol, sorbitol, and erythritol in the chewing gum. It is described that 20 to 85% by weight, more preferably 30 to 80% by weight of the whole chewing gum is desirable.
  • Patent Document 2 relates to a composition for oral cavity.
  • an oral composition that prevents and suppresses bad breath, particularly bad breath caused by methioninase.
  • Claim 1 describes that it contains one or more selected from the group consisting of mannitol, maltitol, sorbitol and a mixture thereof, and is usually 0.1% by mass or more in products and preparations. Preferably, it is blended at a ratio of 1 to 70% by mass.
  • the sample solution containing 1% by mass of maltitol inhibits methionase activity by 20.0%. A report has been made.
  • Patent Document 3 relates to a bad breath component cleaning composition and a composition for oral cavity containing the same, chewing gum and refreshing confectionery in the mouth.
  • the present invention relates to a cleaning composition for cleaning odor components such as indole, skatole, phenol, p-cresol, and the composition for oral cavity.
  • one or more kinds selected from sugar alcohols having 4 to 24 carbon atoms are included.
  • sugar alcohols having 4 to 24 carbon atoms are included.
  • sorbitol, xylitol, lactitol, maltitol, and palatinit are reported to be desirable.
  • those containing erythritol and maltitol showed the most significant reduction in bad breath after 30 minutes of use for subjects with bad breath (sensory evaluation by three specialist panels).
  • Patent Document 4 discloses a bad breath removal agent for phase transition, and in particular, a bad breath removal agent comprising a monoglyceride as a main base and comprising a polymer, a polyol, a bad breath removal active ingredient, and a solvent. From claim 14, it describes that non-fermentable sugar alcohol is included as a bad breath removing active ingredient, and from claim 16, as non-fermentable sugar alcohol, xylitol, sorbitol, erythritol, mannitol, maltitol, lactitol, paratinitol, palatinose. Describes oligosaccharides. Although patent document 4 is evaluating the bad breath removal effect by sensory evaluation using the comparative example and example which contain xylitol, the correlation between the xylitol content and the result of sensory evaluation is not confirmed.
  • An object of the present invention is to provide a bad breath removing agent characterized by suppressing production of volatile sulfur compounds by sugar alcohol.
  • VSC volatile nitrogen compounds
  • lower fatty acids etc.
  • VSC has been reported to show a strong correlation between the odor intensity of the sensory test and the concentration detected from the oral cavity.
  • erythritol, lactitol, and maltitol suppressed the generation of hydrogen sulfide and methyl mercaptan in a pH-independent manner.
  • lactitol and maltitol reduce hydrogen sulfide production to about 40-60% at a concentration of 10% against P. gingivalis, the main causative agent of periodontal disease.
  • the present invention exhibits a remarkable volatile sulfur compound production inhibitory action, it can be used as a preparation such as a mouthwash, a toothpaste, an inhalant, a troche, and chewing gum, candy, tablet confectionery, gummy jelly, It can be used and ingested daily as a food such as biscuits and chocolates, sorbets and beverages, and is effective in improving and preventing bad breath.
  • One embodiment of the present invention is a bad breath remover containing sugar alcohol as an active ingredient.
  • a further embodiment of the present invention is the bad breath remover as described above, wherein the sugar alcohol is lactitol.
  • Another embodiment of the present invention is a mouthwash, a toothpaste, an inhalant, and a troche comprising a bad breath remover containing sugar alcohol as an active ingredient.
  • Still another embodiment of the present invention is a food comprising a bad breath remover containing sugar alcohol as an active ingredient.
  • Still another embodiment of the present invention is a food such as chewing gum, candy, tablet confectionery, gummy jelly, biscuits, chocolate and other confectionery, sorbet, beverage and the like containing a bad breath remover containing sugar alcohol as an active ingredient. is there.
  • Another embodiment of the present invention is a production inhibitor of volatile sulfur compounds by inhibiting methionine and cysteine metabolic pathways containing sugar alcohol as an active ingredient.
  • Still another embodiment of the present invention is the volatile sulfur compound production inhibitor as described above, wherein the sugar alcohol is lactitol or maltitol.
  • Example 1 Sugar alcohol saliva incubation test was performed as follows.
  • Sample preparation As samples, xylitol, erythritol, lactitol, maltitol, and sucrose were used. Each was dissolved in deionized water to an appropriate concentration to obtain a sample solution.
  • Saliva Incubation Test Four healthy adults (A, B, C, D, average age 32.0 years) were subjects, and the test was conducted in duplicate. Between 9:00 am and 9:30 am, 10 ml of unstimulated saliva was collected from each subject (no breakfast or toothpaste on the day of collection). The collected saliva was stored on ice. 0.5 ml of the sample solution was added to 1.0 ml of unstimulated saliva and cultured at 37 ° C. for 23 hours. After incubation for 23 hours, the samples were placed on ice. Before GC analysis, the sample was shaken at 37 ° C. for 15 minutes, an appropriate amount of headspace gas was taken with a syringe, and GC analysis was performed. In the test under neutral conditions, potassium phosphate buffer was added to a final concentration of 20 mM, and the reaction solution was maintained in a neutral region.
  • GC analysis For GC analysis, GC6890 manufactured by Agilent was used. HP-PLOTQ (30m ⁇ 0.53mm ⁇ 40 ⁇ m) is used as the analytical column, initial temperature: 70 ° C / 2.5min, temperature rise: 30 ° C / min, final temperature: 190 ° C / 3.5min, inlet temperature: 200 ° C, Analysis was performed under the conditions of detector: FPD, detector temperature: 200 ° C., flow rate: 20 ml / min. Regarding RT, hydrogen sulfide is 1.1 min, methyl mercaptan is 4.0 min, dimethyl monosulfide is 5.6 min, and dimethyl disulfide is 8.3 min. All samples were performed in duplicate and calculated as an average value.
  • sucrose inhibitory effect of sucrose is pH dependent.
  • the increase in the amount of VSC generated by adding sucrose under neutral conditions is thought to be due to the fact that sucrose becomes a nutrient source for oral bacteria and the number of bacteria that cause bad breath is increased.
  • sucrose becomes a nutrient source for oral bacteria
  • the number of bacteria that cause bad breath is increased.
  • bacteria in the oral cavity increase due to sucrose, but as sucrose is assimilated, lactic acid and the like are discharged, pH is lowered, and methioninase activity and cysteine metabolizing enzyme activity are inhibited.
  • methioninase activity and cysteine metabolizing enzyme activity are inhibited.
  • it is thought that the occurrence of VSC is suppressed because the growth of bad breath causing bacteria is suppressed.
  • FIG. 2 shows the results of the saliva incubation test described above with xylitol at final concentrations of 1.43% and 5.7%. In this test using xylitol, there was no significant change in the generation amount of hydrogen sulfide / methyl mercaptan and the pH of the reaction solution in all panelists.
  • Example 2 Bacterial metabolism inhibition test of sugar alcohols was performed as follows.
  • F. nucleatum was anaerobically cultured in 3% THB medium containing 0.05% L-cysteine hydrochloride for 1 day. After culturing for 1 day, it was confirmed that the absorbance at 550 nm was 0.8 or more, and the supernatant was discarded after centrifugation at 5000 rpm for 4 minutes. Suspend the bacterial cells in physiological saline and repeat the same procedure. Suspend the bacterial cells in physiological saline twice the amount of the original bacterial solution, and use it for ice cooling. .
  • P. gingivalis was anaerobically cultured in TSB medium (3% TripticaseticSoy Broth, 0.3% Yeast Extract, 0.0005% hemin, 0.00005% menadione) for 1 day. After culturing for 1 day, it was confirmed that the absorbance at 550 nm was 1.4 or more, and a bacterial solution was prepared in the same manner as described above.
  • TSB medium 3% TripticaseticSoy Broth, 0.3% Yeast Extract, 0.0005% hemin, 0.00005% menadione
  • Cysteine metabolic pathway inhibition test A cysteine metabolic pathway inhibition test was conducted in the same manner as the methionine metabolic pathway inhibition test, except that L-cysteine was used as a substrate.
  • gingivalis cysteine metabolic pathway lactitol, maltitol, and sucrose reduced hydrogen sulfide production to about 40-60% at a final concentration of 10%.
  • no clear effect was observed for xylitol and erythritol.
  • a mouthwash, a toothpaste, a mouth spray, a troche, a chewing gum, a candy, a tablet candy, a gummy jelly, and a beverage containing the halitosis remover of the present invention were produced by conventional methods. Their formulations are shown below. Note that the scope of the present invention is not limited by these.
  • Example 3 A mouthwash was prepared according to the following formulation. Ethanol 2.0% by weight Lactitol 10.0 Fragrance 1.0 Water remaining 100.0
  • Example 4 A toothpaste was produced according to the following formulation. Calcium carbonate 40.0% by weight Glycerin 10.0 Maltitol 20.0 Carboxymethylcellulose 2.0 Sodium ralyl sulfate 2.0 Fragrance 1.0 Saccharin 0.1 Chlorhexidine 0.01 Water remaining 100.0
  • Example 5 A mouse spray was produced according to the following formulation. Ethanol 10.0% by weight Glycerin 5.0 Lactitol 10.0 Maltitol 10.0 Fragrance 0.05 Coloring 0.001 Water remaining 100.0
  • Example 6 A lozenge was produced according to the following formulation. Maltitol 72.3 wt% Xylitol 20.0 Gum arabic 6.0 Fragrance 1.0 Sodium monofluorophosphate 0.7 100.0
  • Chewing gum was manufactured according to the following formulation. Gum base 20.0% by weight Maltitol 45.0 Lactitol 33.0 Fragrance 2.0 100.0
  • Example 8 Candy was manufactured according to the following prescription. Maltitol 50.0% by weight Reduced water candy 34.0 Citric acid 2.0 Fragrance 0.2 Water remaining 100.0
  • Example 9 Tablet confectionery was produced according to the following prescription. Maltitol 76.1% by weight Lactitol 19.0 Sucrose fatty acid ester 0.2 Fragrance 0.2 Water 4.5 100.0
  • Example 10 Gummy jelly was manufactured according to the following prescription. Gelatin 60.0% by weight Reduced water candy 21.40 Maltitol 11.5 Vegetable oil 4.5 Malic acid 2.0 Fragrance 0.5 100.0
  • Example 11 A beverage was produced according to the following formulation. Orange juice 30.0% by weight Lactitol 15.0 Citric acid 0.1 Vitamin C 0.04 Fragrance 0.1 Water remaining 100.0
  • the bad breath remover containing the sugar alcohol of the present invention can be applied to gums, candy, tablet confectionery, etc., and can also be applied to bad breath removal specific health foods.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is a bad breath-removing agent which contains a sugar alcohol as an active ingredient. Specifically disclosed is a breath-removing agent which is characterized by the inhibitory activity of a sugar alcohol on the production of a volatile sulfur compound. The breath-removing agent contains a sugar alcohol, in particular lactitol, as an active ingredient.

Description

口臭除去剤Bad breath remover
 本発明は、糖アルコールによる揮発性硫黄化合物の産生抑制を特徴とする口臭除去剤に関する。 The present invention relates to a bad breath removing agent characterized by suppressing production of volatile sulfur compounds by sugar alcohol.
 日本において、約3万人を対象とした厚生省保健福祉動向調査によると、口腔内に何らかの歯科的問題を持つ人が70%認められ、その内の14.5%の人が「口臭が気になる」(複数回答可)と回答しており、歯周疾患やう蝕に関連する訴えに次いで4番目に高く、年々口臭に対する関心が高まっている。口腔から発せられる不快な臭いの成分として、揮発性硫黄化合物(VSC)、揮発性窒素化合物、低級脂肪酸などが報告されている。これらのうち、官能試験の臭い強度と、口腔内から検出される濃度との間で強い相関性を示すことが報告されているのはVSCである。口腔内気体中から検出されるVSCには、硫化水素、メチルメルカプタン、ジメチルスルフィドの3種類が単独、あるいは混在して認められる。他の物質は呼気中から検出されるが、ヒトのにおい閾値以上の濃度を検出することは稀である。 According to the Ministry of Health, Welfare and Health Trend Survey of approximately 30,000 people in Japan, 70% of people with dental problems in the oral cavity are recognized, and 14.5% of those who are worried about bad breath (Multiple answers allowed), the fourth highest after complaints related to periodontal disease and caries, and interest in bad breath is increasing year by year. As an unpleasant odor component emitted from the oral cavity, volatile sulfur compounds (VSC), volatile nitrogen compounds, lower fatty acids and the like have been reported. Of these, VSC is reported to show a strong correlation between the odor intensity of the sensory test and the concentration detected in the oral cavity. VSCs detected in oral gas include hydrogen sulfide, methyl mercaptan, and dimethyl sulfide, either alone or in combination. Other substances are detected in exhaled breath, but it is rare to detect concentrations above the human odor threshold.
 口臭の主原因であるVSCは、口腔内細胞の残骸や食物中の含硫アミノ酸を基質として、口腔内の嫌気性菌の代謝によって産生される。特に、細菌のcystathionine-β-syntase、cystathionine-γ-lyaseの関与により、システインから硫化水素が、L-methionine-γ-lyaseの関与によりメチオニンからメチルメルカプタンが産生される。 VSC, the main cause of bad breath, is produced by the metabolism of anaerobic bacteria in the oral cavity using debris from oral cells and sulfur-containing amino acids in food as a substrate. In particular, hydrogen sulfide is produced from cysteine due to the involvement of bacterial cystathionine-β-syntase and cystathionine-γ-lyase, and methyl mercaptan is produced from methionine due to the involvement of L-methionine-γ-lyase.
 VSCは悪臭物質としてだけではなく、強力な生体毒性を有する。VSCにより、バリアー機能を持つ粘膜の透過性を亢進し、また繊維芽細胞のコラーゲン合成阻害、および上皮基底膜の損傷を促進し、合成を阻害することが報告されている。特に、硫化水素はヒト白血球を用いた実験で、活性酸素の産生を増加させ、一方で、スーパーオキサイドディスムターゼ(SOD)を強く阻害し、VSCが発癌性を有する可能性が示唆されている。そのため、口臭を抑制することが、口腔の健康を維持していく上で重要な意義になってくる。 VSC is not only a malodorous substance but also has a strong biotoxicity. It has been reported that VSC enhances permeability of mucous membranes having a barrier function, promotes collagen synthesis inhibition of fibroblasts and damage of epithelial basement membrane, and inhibits synthesis. In particular, in experiments using human leukocytes, hydrogen sulfide increases the production of active oxygen, while strongly inhibiting superoxide dismutase (SOD), suggesting the possibility that VSC has carcinogenicity. Therefore, suppressing bad breath becomes important in maintaining oral health.
 近年、口腔ケア、特に抗う蝕という観点から、糖アルコールの需要は増加しているものの、口臭に及ぼす糖アルコールの影響に関しては未解明のままである。 In recent years, the demand for sugar alcohol has increased from the viewpoint of oral care, particularly anti-caries, but the influence of sugar alcohol on bad breath remains unclear.
 そこで、現在、シュガーレスガムに使用されている糖アルコールであるキシリトール、マルチトール、エリスリトール、およびラクチトールに関して口臭にどのような影響があるのか、唾液インキュベート試験、菌代謝阻害試験により評価を行った。 Therefore, the influence of bad breath on the xylitol, maltitol, erythritol, and lactitol sugar sugars currently used in sugarless gum was evaluated by a saliva incubation test and a bacterial metabolism inhibition test.
 糖アルコール類と口臭、消臭低減作用に関連する先行技術として、以下の特許文献がある。 There are the following patent documents as prior art related to sugar alcohols, bad breath, and deodorant reducing action.
 特許文献1は、チューインガムの発明に関し、リン酸2水素カルシウム、グリセロリン酸カルシウムを含む組成物を、ガムベースと共に混練し、チューインガムを作製し、これを咀嚼し、口臭効果の即効性と持続性を10名のパネリストが官能評価した。その結果、キシリトール60%配合ガムの場合、即効性を認めたのが10/10人、持続性を認めたのが7/10人であった。これに対し、キシリトールをショ糖60%配合に置き換えた場合、即効性を認めたのが5/10人、持続性を認めたのが3/10人であった。尚、咀嚼時間、或いは即効性・持続性を認める具体的な時間についての記載はない。特許文献1の発明の詳細な説明0017において、チューインガム中にキシリトール、ソルビトール、エリスリトールからなる群から、1種又は2種以上の糖アルコールを含有することで口臭除去効果が向上し、その配合量はチューインガム全体の20~85質量%、さらに30~80質量%が望ましいと記載されている。 Patent Document 1 relates to the invention of chewing gum. A composition containing calcium dihydrogen phosphate and calcium glycerophosphate is kneaded with a gum base to produce a chewing gum, which is chewed, and has an immediate effect and sustainability of a bad breath effect. Panelists made a sensory evaluation. As a result, in the case of 60% xylitol blended gum, 10/10 people recognized immediate effect and 7/10 people recognized durability. On the other hand, when xylitol was replaced with 60% sucrose, 5/10 people recognized immediate effect and 3/10 people recognized sustainability. In addition, there is no description about the mastication time or the specific time in which immediate effect / sustainability is recognized. In the detailed description 0017 of the invention of Patent Document 1, the effect of removing bad breath is improved by containing one or more sugar alcohols from the group consisting of xylitol, sorbitol, and erythritol in the chewing gum. It is described that 20 to 85% by weight, more preferably 30 to 80% by weight of the whole chewing gum is desirable.
 特許文献2は、口腔用組成物に関する。口臭、特にメチオニナーゼに起因する口臭を防止、抑制する口腔用組成物を開示する。請求項1にマンニトール、マルチトール、ソルビトール及びこれらの混合物からなる群より選択される1種、または2種以上を含むことを記載しており、製品、製剤中において、通常0.1質量%以上、好ましくは1~70質量%の割合で配合している。試料液にPorphyromonas.gingivalisの菌体懸濁液、メチオニンを加え、メチルメルカプタンを測定した結果、マルチトール1質量%を含む試料液では無添加と比較してメチオナーゼ活性を20.0%阻害するとの報告がなされている。 Patent Document 2 relates to a composition for oral cavity. Disclosed is an oral composition that prevents and suppresses bad breath, particularly bad breath caused by methioninase. Claim 1 describes that it contains one or more selected from the group consisting of mannitol, maltitol, sorbitol and a mixture thereof, and is usually 0.1% by mass or more in products and preparations. Preferably, it is blended at a ratio of 1 to 70% by mass. As a result of measuring the methyl mercaptan after adding Porphyromonas.gingivalis cell suspension and methionine to the sample solution, the sample solution containing 1% by mass of maltitol inhibits methionase activity by 20.0%. A report has been made.
 特許文献3は、口臭成分洗浄組成物及びそれを含む口腔用組成物、チューインガム及び口中清涼菓子に関する。特に、口腔内のインドール、スカトール、フェノール、p-クレゾール等の匂い成分を洗浄する洗浄組成物、または口腔用組成物に関する。請求項4より炭素数4~24の糖アルコールから選ばれる1種又は2種以上を含むことを記載しており、請求項5及び発明の詳細な説明0019より、口臭成分洗浄効果の高さから、上記の糖アルコールのうち特にソルビトール、キシリトール、ラクチトール、マルチトール、パラチニットが望ましいと報告されている。歯磨き剤を用いた実施例において、エリスリトール、マルチトールを配合したものは、口臭を有する被験者に対する使用30分後の口臭の低減が最も顕著であった(専門パネル3名による官能評価)。 Patent Document 3 relates to a bad breath component cleaning composition and a composition for oral cavity containing the same, chewing gum and refreshing confectionery in the mouth. In particular, the present invention relates to a cleaning composition for cleaning odor components such as indole, skatole, phenol, p-cresol, and the composition for oral cavity. According to claim 4, it is described that one or more kinds selected from sugar alcohols having 4 to 24 carbon atoms are included. Among the above sugar alcohols, sorbitol, xylitol, lactitol, maltitol, and palatinit are reported to be desirable. In the examples using dentifrices, those containing erythritol and maltitol showed the most significant reduction in bad breath after 30 minutes of use for subjects with bad breath (sensory evaluation by three specialist panels).
 特許文献4は、相転移の口臭除去剤を開示し、特に、モノグリセリドを主基剤とし、ポリマー、ポリオール、口臭除去有効成分及び溶剤を含んでなる口臭除去剤を開示している。請求項14より、口臭除去有効成分として非発酵性糖アルコールを含むことを記載し、請求項16より、非発酵性糖アルコールとして、キシリトール、ソルビトール、エリスリトール、マンニトール、マルチトール、ラクチトール、パラチニトール、パラチノース、オリゴ糖を記載している。特許文献4は、キシリトールを含んだ比較例、実施例を用いて官能評価による口臭除去効果の評価を行っているが、キシリトール含量と官能評価の結果に相関性は確認されていない。 Patent Document 4 discloses a bad breath removal agent for phase transition, and in particular, a bad breath removal agent comprising a monoglyceride as a main base and comprising a polymer, a polyol, a bad breath removal active ingredient, and a solvent. From claim 14, it describes that non-fermentable sugar alcohol is included as a bad breath removing active ingredient, and from claim 16, as non-fermentable sugar alcohol, xylitol, sorbitol, erythritol, mannitol, maltitol, lactitol, paratinitol, palatinose. Describes oligosaccharides. Although patent document 4 is evaluating the bad breath removal effect by sensory evaluation using the comparative example and example which contain xylitol, the correlation between the xylitol content and the result of sensory evaluation is not confirmed.
 以上のように、従来技術においては、キシリトール、エリスリトール、マルチトールについては、実施例も含め、口臭低減効果を示す開示が認められた。しかし、ラクチトールについては、請求項に組成物、有効成分としての記述はあるものの、具体的な消臭効果を示す実施例は全く認められなかった。 As described above, in the prior art, disclosure showing a bad breath reducing effect was recognized for xylitol, erythritol, and maltitol, including the examples. However, with regard to lactitol, although there is a description as a composition and an active ingredient in the claims, no examples showing a specific deodorizing effect were found.
特開2006-325455号公報JP 2006-325455 A 特開2003-160458号公報JP 2003-160458 A 特開2004-203872号公報JP 2004-203872 A 特表2009-500399Special table 2009-500399
 本発明は、糖アルコールによる揮発性硫黄化合物の産生抑制を特徴とする口臭除去剤を提供することを目的とする。 An object of the present invention is to provide a bad breath removing agent characterized by suppressing production of volatile sulfur compounds by sugar alcohol.
 口腔から発せられる不快な臭いの成分として、VSC、揮発性窒素化合物、低級脂肪酸などが報告されている。これらのうち、VSCは官能試験の臭い強度と、口腔内から検出される濃度との間で強い相関性を示すことが報告されている。糖アルコールの口臭に対する影響を確認するため、各糖アルコールのVSC発生に対する影響を調べたところ、エリスリトール、ラクチトール、マルチトールがpH非依存的に硫化水素、メチルメルカプタンの発生を抑制することを確認した。また、歯周病の主要な原因菌であるP.gingivalisに対し、ラクチトール、マルチトールが10%の濃度で硫化水素の産生量を約40~60%まで減少させることを確認した。 VSC, volatile nitrogen compounds, lower fatty acids, etc. have been reported as unpleasant odor components emitted from the oral cavity. Among these, VSC has been reported to show a strong correlation between the odor intensity of the sensory test and the concentration detected from the oral cavity. In order to confirm the effects of sugar alcohols on bad breath, the effects of each sugar alcohol on VSC generation were examined, and it was confirmed that erythritol, lactitol, and maltitol suppressed the generation of hydrogen sulfide and methyl mercaptan in a pH-independent manner. . It was also confirmed that lactitol and maltitol reduce hydrogen sulfide production to about 40-60% at a concentration of 10% against P. gingivalis, the main causative agent of periodontal disease.
 本発明は、顕著な揮発性硫黄化合物の産生抑制作用を示すことから、含そう剤、練り歯磨き剤、吸入剤、トローチ剤などの製剤として、また、チューインガム、キャンディ、錠菓、グミ・ゼリー、ビスケット、チョコレート等の菓子、シャーベット、飲料等の食品として日常的に利用、摂取することが可能であり、口臭の改善及び予防に有効である。 Since the present invention exhibits a remarkable volatile sulfur compound production inhibitory action, it can be used as a preparation such as a mouthwash, a toothpaste, an inhalant, a troche, and chewing gum, candy, tablet confectionery, gummy jelly, It can be used and ingested daily as a food such as biscuits and chocolates, sorbets and beverages, and is effective in improving and preventing bad breath.
スクロースのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of sucrose. キシリトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of a xylitol. エリスリトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of an erythritol. ラクチトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of lactitol. 中性条件下のラクチトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of the lactitol under neutral conditions. マルチトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of maltitol. 中性条件下のマルチトールのVSC発生に対する影響を示すグラフである。It is a graph which shows the influence with respect to VSC generation | occurrence | production of maltitol under neutral conditions. 糖アルコール類の菌代謝阻害効果を示すグラフである。It is a graph which shows the microbial metabolism inhibitory effect of sugar alcohol. 糖アルコール類の菌代謝阻害効果を示すグラフである。It is a graph which shows the microbial metabolism inhibitory effect of sugar alcohol.
 本願発明の一実施形態は、糖アルコールを有効成分とする口臭除去剤である。 One embodiment of the present invention is a bad breath remover containing sugar alcohol as an active ingredient.
 本発明の更なる一実施形態は、前記糖アルコールが、ラクチトールである上記に記載の口臭除去剤である。 A further embodiment of the present invention is the bad breath remover as described above, wherein the sugar alcohol is lactitol.
 本発明の別の一実施形態は、糖アルコールを有効成分とする口臭除去剤からなる、含そう剤、練り歯磨き剤、吸入剤、およびトローチ剤である。 Another embodiment of the present invention is a mouthwash, a toothpaste, an inhalant, and a troche comprising a bad breath remover containing sugar alcohol as an active ingredient.
 本発明の更なる別の一実施形態は、糖アルコールを有効成分とする口臭除去剤からなる食品である。 Still another embodiment of the present invention is a food comprising a bad breath remover containing sugar alcohol as an active ingredient.
 本発明の更なる別の一実施形態は、糖アルコールを有効成分とする口臭除去剤を含有するチューインガム、キャンディ、錠菓、グミ・ゼリー、ビスケット、チョコレート等の菓子、シャーベット、飲料等の食品である。 Still another embodiment of the present invention is a food such as chewing gum, candy, tablet confectionery, gummy jelly, biscuits, chocolate and other confectionery, sorbet, beverage and the like containing a bad breath remover containing sugar alcohol as an active ingredient. is there.
 本発明のもう一つの実施形態は、糖アルコールを有効成分とするメチオニンおよびシステイン代謝経路阻害による揮発性硫黄化合物の産生抑制剤である。 Another embodiment of the present invention is a production inhibitor of volatile sulfur compounds by inhibiting methionine and cysteine metabolic pathways containing sugar alcohol as an active ingredient.
 本発明の更にもう一つの実施態様は、前記糖アルコールが、ラクチトール、マルチトールである上記に記載の揮発性硫黄化合物の産生抑制剤である。 Still another embodiment of the present invention is the volatile sulfur compound production inhibitor as described above, wherein the sugar alcohol is lactitol or maltitol.
 以下、本願発明を具体的実施例により詳細に説明するが、これらにより本願発明が限定されるものではない。 Hereinafter, the present invention will be described in detail by way of specific examples, but the present invention is not limited thereto.
(実施例1)
 糖アルコール類の唾液インキュベート試験を以下のように行った。
Example 1
Sugar alcohol saliva incubation test was performed as follows.
1-1. 試料の準備
 試料としては、キシリトール、エリスリトール、ラクチトール、マルチトール、スクロースを用いた。それぞれ、適当な濃度になるよう脱イオン水に溶解し、試料溶液とした。
1-1. Sample preparation As samples, xylitol, erythritol, lactitol, maltitol, and sucrose were used. Each was dissolved in deionized water to an appropriate concentration to obtain a sample solution.
1-2. 唾液インキュベート試験
 健常な成人4名(A,B,C,D,平均年齢32.0才)を被験者とし、試験は二連で実施した。朝9:00~9:30の間に、各被験者から無刺激唾液を10ml採取した(採取する日は、朝食を取らず、歯磨きをしない)。採取した唾液は氷上で保存した。無刺激唾液1.0mlに試料溶液0.5mlを加え、37℃で23時間培養した。23時間培養後、サンプルを氷上に置いた。GC分析前にサンプルを37℃で15分間振とうし、ヘッドスペースガスをシリンジにより適当量とり、GC分析を行った。尚、中性条件下での試験は、リン酸カリウムバッファーを最終濃度20mMになるよう加え、反応液を中性領域に維持した。
1-2. Saliva Incubation Test Four healthy adults (A, B, C, D, average age 32.0 years) were subjects, and the test was conducted in duplicate. Between 9:00 am and 9:30 am, 10 ml of unstimulated saliva was collected from each subject (no breakfast or toothpaste on the day of collection). The collected saliva was stored on ice. 0.5 ml of the sample solution was added to 1.0 ml of unstimulated saliva and cultured at 37 ° C. for 23 hours. After incubation for 23 hours, the samples were placed on ice. Before GC analysis, the sample was shaken at 37 ° C. for 15 minutes, an appropriate amount of headspace gas was taken with a syringe, and GC analysis was performed. In the test under neutral conditions, potassium phosphate buffer was added to a final concentration of 20 mM, and the reaction solution was maintained in a neutral region.
1-3. GC分析
 GC分析に関しては、すべてAgilent社製のGC6890を用いた。分析カラムはHP-PLOTQ(30m×0.53mm×40μm)を用い、初期温度:70℃/2.5min、昇温:30℃/min、終温度:190℃/3.5min、注入口温度:200℃、検出器:FPD、検出器温度:200℃、流量:20ml/minの条件で分析した。RTに関しては、硫化水素が1.1min、メチルメルカプタンが4.0min、ジメチルモノスルフィドが5.6min、ジメチルジスルフィドが8.3minである。全てのサンプルは二連で行い、平均値として算出した。
1-3. GC analysis For GC analysis, GC6890 manufactured by Agilent was used. HP-PLOTQ (30m × 0.53mm × 40μm) is used as the analytical column, initial temperature: 70 ° C / 2.5min, temperature rise: 30 ° C / min, final temperature: 190 ° C / 3.5min, inlet temperature: 200 ° C, Analysis was performed under the conditions of detector: FPD, detector temperature: 200 ° C., flow rate: 20 ml / min. Regarding RT, hydrogen sulfide is 1.1 min, methyl mercaptan is 4.0 min, dimethyl monosulfide is 5.6 min, and dimethyl disulfide is 8.3 min. All samples were performed in duplicate and calculated as an average value.
1-4. 結果
1. スクロースの効果
 上記唾液インキュベート試験において、スクロースを最終濃度0.057、0.114%になるように添加した。その結果、最終濃度が0.057%のときは、pHに変化はなく、VSCの発生にもほとんど変化がなかったが、最終濃度が0.114%のときに、pHが5.6と酸性に傾き、硫化水素・メチルメルカプタンの発生も抑制された。これらの結果を図1に示す。
1-4. Result 1. Effect of sucrose In the saliva incubation test, sucrose was added to a final concentration of 0.057 and 0.114%. As a result, when the final concentration was 0.057%, there was no change in pH, and there was almost no change in the occurrence of VSC. Generation of methyl mercaptan was also suppressed. These results are shown in FIG.
 なお、反応液にリン酸バッファーを加えて培養したところ、スクロースの最終濃度が0.114%でも、反応液のpHは中性付近に保たれ、硫化水素・メチルメルカプタンの発生量は逆に上昇した。 In addition, when the phosphate buffer was added to the reaction solution and cultured, even when the final sucrose concentration was 0.114%, the pH of the reaction solution was maintained near neutral, and the amount of hydrogen sulfide / methyl mercaptan generated was increased.
 スクロースのVSC抑制効果は、pH依存的なものであることが分かった。中性条件において、スクロースを添加することでVSCの発生量が上昇することについて、スクロースが口腔内細菌の栄養源となり、口臭原因菌が増加したことに起因するのではないかと考えられる。バッファーが無い条件では、スクロースにより、口腔内細菌が増加するが、スクロースが資化されることにより、乳酸などが排出され、pHが低下し、メチオニナーゼ活性、システイン代謝酵素活性が阻害されるため、もしくは口臭原因菌の増殖が抑制されるためにVSCの発生が抑制されると考えられる。 It was found that the VSC inhibitory effect of sucrose is pH dependent. The increase in the amount of VSC generated by adding sucrose under neutral conditions is thought to be due to the fact that sucrose becomes a nutrient source for oral bacteria and the number of bacteria that cause bad breath is increased. In the absence of a buffer, bacteria in the oral cavity increase due to sucrose, but as sucrose is assimilated, lactic acid and the like are discharged, pH is lowered, and methioninase activity and cysteine metabolizing enzyme activity are inhibited. Alternatively, it is thought that the occurrence of VSC is suppressed because the growth of bad breath causing bacteria is suppressed.
2. キシリトールの効果
 キシリトールに関して、最終濃度1.43%、5.7%の濃度で上記した唾液インキュベート試験を行った結果を図2に示す。キシリトールを使用した本試験では全パネラーにおいて、硫化水素・メチルメルカプタンの発生量、および反応液のpHに大きな変化はなかった。
2. Effect of Xylitol FIG. 2 shows the results of the saliva incubation test described above with xylitol at final concentrations of 1.43% and 5.7%. In this test using xylitol, there was no significant change in the generation amount of hydrogen sulfide / methyl mercaptan and the pH of the reaction solution in all panelists.
3. エリスリトールの効果
 エリスリトールに関しては、図3に示すように、エリスリトールを添加しても、反応液のpHは変化しないが、硫化水素・メチルメルカプタンの発生量は添加濃度依存的に抑制された。
3. Effect of Erythritol As shown in FIG. 3, even when erythritol was added, the pH of the reaction solution did not change, but the amount of hydrogen sulfide / methyl mercaptan generated was suppressed depending on the addition concentration.
4. ラクチトールの効果
 ラクチトールに関しては、図4-1に示すように、ラクチトールの添加により、反応液のpHが変わらない人(2/4名)とpHが低下する人(2/4名)がいた。どちらのパネラーにおいても、硫化水素・メチルメルカプタンの発生量は抑制された。
4). Effect of Lactitol As shown in FIG. 4-1, there was a person (2/4) who did not change the pH of the reaction solution and a person (2/4) whose pH decreased due to the addition of lactitol. In both panelists, the generation of hydrogen sulfide and methyl mercaptan was suppressed.
 また、図4-2に示すように、中性条件において、ラクチトールの効果を確認したところ、中性条件においてもメチルメルカプタンの発生を抑制した。 Further, as shown in FIG. 4-2, when the effect of lactitol was confirmed under neutral conditions, the generation of methyl mercaptan was also suppressed under neutral conditions.
5. マルチトールの効果 
 マルチトールに関しては、マルチトールの添加により、反応液のpHが変わらない人(1/4名)とpHが低下する人(3/4名)がいた。図5-1に示すように、全パネラーにおいて、マルチトールを添加しても硫化水素の発生量にほとんど変化は見られなかった。一方、メチルメルカプタンの発生はマルチトールの添加により抑制された。中性条件下では、図5-2に示すように、硫化水素の発生量は上昇する傾向にあったが、メチルメルカプタンの発生は抑制された。
5. The effect of maltitol
Regarding maltitol, there were some people (1/4 people) who did not change the pH of the reaction solution due to the addition of maltitol and others (3/4 people) whose pH decreased. As shown in FIG. 5-1, in all the panelists, even when maltitol was added, the amount of hydrogen sulfide generated hardly changed. On the other hand, the generation of methyl mercaptan was suppressed by the addition of maltitol. Under neutral conditions, as shown in FIG. 5-2, the generation amount of hydrogen sulfide tended to increase, but the generation of methyl mercaptan was suppressed.
 以上の結果から、in vitro試験系において、キシリトールがVSCの発生に悪影響を及ぼすことはないということが分かった。また、ラクチトール・マルチトール・エリスリトールに関してはpH非依存的にVSCの発生を抑制することが分かった。特に、ラクチトールに関してはエリスリトールよりも抑制効果が強かった。 From the above results, it was found that xylitol does not adversely affect the occurrence of VSC in the in-vitro test system. In addition, it was found that lactitol, maltitol, and erythritol suppress the generation of VSC in a pH-independent manner. In particular, lactitol had a stronger inhibitory effect than erythritol.
(実施例2)
 糖アルコール類の菌代謝阻害試験を以下のように行った。
(Example 2)
Bacterial metabolism inhibition test of sugar alcohols was performed as follows.
2-1. 菌液の準備
 菌株としては、F.nucleatumとP.gingivalisを用いた。
2-1. Preparation of fungus F. nucleatum and P. gingivalis were used as strains.
 F.nucleatumはL-システイン塩酸塩を0.05%含む3%THB培地で嫌気的に1日培養した。1日培養後、550nmにおける吸光度が0.8以上であることを確認し、5000rpmで4分間遠沈し上清を捨てた。菌体を生理食塩水に懸濁させ、再び同様の操作を行い、得られた菌体をもとの菌液の2倍量の生理食塩水に懸濁させ、氷冷しながら試験に供した。 F. nucleatum was anaerobically cultured in 3% THB medium containing 0.05% L-cysteine hydrochloride for 1 day. After culturing for 1 day, it was confirmed that the absorbance at 550 nm was 0.8 or more, and the supernatant was discarded after centrifugation at 5000 rpm for 4 minutes. Suspend the bacterial cells in physiological saline and repeat the same procedure. Suspend the bacterial cells in physiological saline twice the amount of the original bacterial solution, and use it for ice cooling. .
 P.gingivalisはTSB培地(3% Tripticase Soy Broth, 0.3% Yeast Extract, 0.0005% hemin, 0.00005% menadione)で嫌気的に1日培養した。1日培養後、550nmにおける吸光度が1.4以上であることを確認し、上記と同様の方法で菌液の調製を行った。 P. gingivalis was anaerobically cultured in TSB medium (3% TripticaseticSoy Broth, 0.3% Yeast Extract, 0.0005% hemin, 0.00005% menadione) for 1 day. After culturing for 1 day, it was confirmed that the absorbance at 550 nm was 1.4 or more, and a bacterial solution was prepared in the same manner as described above.
2-2. メチオニン代謝経路阻害試験
 試験管に0.1Mリン酸緩衝液(pH6.5)2.47mlと被験液0.03mlを入れた。ヘッドスペースを混合ガス(窒素:水素:炭酸ガス=8:1:1)で置換後、シリコン栓で密封、攪拌し、37℃の水浴に保温した。5分経過後菌液0.2mlを、ツベルクリン注射器を用いて注入し、攪拌し保温した。5分後にL-メチオニン溶液(0.5%)0.3mlを、ツベルクリン注射器を用いて注入、攪拌し、10分間37℃で保温した。ヘッドスペースガス500μlを抜き取りGC分析でメチルメルカプタン量を測定した。GC分析条件は上記1-3と同様に行った。
2-2. Methionine metabolic pathway inhibition test 2.47 ml of 0.1 M phosphate buffer (pH 6.5) and 0.03 ml of the test solution were placed in a test tube. The head space was replaced with a mixed gas (nitrogen: hydrogen: carbon dioxide gas = 8: 1: 1), sealed with a silicon stopper, stirred, and kept in a 37 ° C. water bath. After 5 minutes, 0.2 ml of the bacterial solution was injected using a tuberculin syringe, stirred and kept warm. After 5 minutes, 0.3 ml of L-methionine solution (0.5%) was injected using a tuberculin syringe, stirred, and kept at 37 ° C. for 10 minutes. A 500 μl headspace gas was withdrawn and the amount of methyl mercaptan was measured by GC analysis. The GC analysis conditions were the same as in 1-3 above.
2-3. システイン代謝経路阻害試験
 基質としてL-システインを使用した以外は、上記メチオニン代謝経路阻害試験と同様な方法でシステイン代謝経路阻害試験を行った。
2-3. Cysteine metabolic pathway inhibition test A cysteine metabolic pathway inhibition test was conducted in the same manner as the methionine metabolic pathway inhibition test, except that L-cysteine was used as a substrate.
2-4.結果
1. メチオニン代謝経路阻害試験
 Fusobacterium nucleatum(以下、F.nucleatumと略す)およびPorphyromonas gingivalis(以下、P.gingivalisと略す)メチオニン代謝経路に対する、糖アルコールおよびスクロースの阻害活性を確認した結果を図6-1の(a)、(b)に示す。F.nucleatumメチオニン代謝経路に対しては、ポジティブコントロールである塩化亜鉛はfinal 100ppmでメチルメルカプタンの発生量を40%(コントロールを100%として)まで減少させた。一方、どの糖アルコールも、final 10%の濃度ではメチルメルカプタンの発生量を80%程度まで抑制し、非常に弱いながらメチオニン代謝阻害活性が認められた。また、P.gingivalisのメチオニン代謝経路に対しては、ポジティブコントロールの塩化亜鉛がメチルメルカプタンの発生量を23%まで抑制した。また、ラクチトール、マルチトールは弱いながらもメチルメルカプタンの発生量を80~90%程度まで抑制したが、キシリトール、エリスリトールについては明確な阻害効果が認められなかった。
2-4. Result 1. Methionine Metabolic Pathway Inhibition Test The results of confirming the inhibitory activity of sugar alcohol and sucrose on Fusobacterium nucleatum (hereinafter abbreviated as F. nucleatum) and Porphyromonas gingivalis (hereinafter abbreviated as P. gingivalis) methionine metabolic pathway are shown in FIG. Shown in (a) and (b). For the F. nucleatum methionine metabolic pathway, the positive control zinc chloride reduced the amount of methyl mercaptan generated to 40% (100% control) at final 100 ppm. On the other hand, all sugar alcohols suppressed methyl mercaptan generation to about 80% at a final concentration of 10%, and were observed to have a very weak methionine metabolism inhibitory activity. In addition, for the methionine metabolic pathway of P. gingivalis, the positive control zinc chloride suppressed the generation of methyl mercaptan by 23%. Although lactitol and maltitol were weak, the amount of methyl mercaptan produced was suppressed to about 80 to 90%, but no clear inhibitory effect was observed for xylitol and erythritol.
2. システイン代謝経路阻害試験
 F.nucleatumおよびP.gingivalisシステイン代謝経路に対する、糖アルコールおよびスクロースの阻害活性を確認した結果を図6-2の(c)、(d)に示す。F.nucleatumシステイン代謝経路に対しては、キシリトール、エリスリトール、ラクチトール、マルチトールはfinal 10%の濃度で硫化水素の産生量を約60~80%近くまで減少させた。スクロースに関しては、硫化水素の発生量を約40%まで抑制した。また、P.gingivalisシステイン代謝経路に対しては、ラクチトール、マルチトール、スクロースがfinal 10%の濃度で硫化水素の産生量を約40~60%まで減少させた。一方、キシリトール、エリスリトールに関しては、明瞭な効果は認められなかった。
2. Cysteine Metabolic Pathway Inhibition Test The results of confirming the inhibitory activity of sugar alcohol and sucrose on the F.nucleatum and P.gingivalis cysteine metabolic pathways are shown in FIGS. 6-2 (c) and (d). For the F. nucleatum cysteine metabolic pathway, xylitol, erythritol, lactitol, and maltitol reduced hydrogen sulfide production to about 60-80% at a final 10% concentration. Regarding sucrose, the amount of hydrogen sulfide generated was suppressed to about 40%. For P. gingivalis cysteine metabolic pathway, lactitol, maltitol, and sucrose reduced hydrogen sulfide production to about 40-60% at a final concentration of 10%. On the other hand, no clear effect was observed for xylitol and erythritol.
 以上の結果から、F.nucleatumに対しては、キシリトール、エリスリトール、ラクチトール、マルチトールがメチオニン、システインの両代謝経路を弱いながら阻害している。 From the above results, for F. nucleatum, xylitol, erythritol, lactitol, and maltitol inhibit both methionine and cysteine metabolic pathways, although they are weak.
 一方、P.gingivalisに対しては、ラクチトールとマルチトールのみが、システイン代謝経路を強く阻害している。したがって、糖アルコールの口臭抑制作用の一機構としてシステイン・メチオニン代謝阻害効果が起因している可能性が示唆された。 On the other hand, for P. gingivalis, only lactitol and maltitol strongly inhibit the cysteine metabolic pathway. Therefore, it was suggested that the cysteine / methionine metabolism inhibitory effect may be caused as a mechanism of the halitosis suppression action of sugar alcohol.
 次に、本発明の口臭除去剤を含有する含そう剤、練り歯磨き、マウススプレー、トローチ、チューインガム、キャンディ、錠菓、グミゼリー、飲料を常法にて製造した。以下にそれらの処方を示した。なお、これらによって本発明品の範囲を制限するものではない。 Next, a mouthwash, a toothpaste, a mouth spray, a troche, a chewing gum, a candy, a tablet candy, a gummy jelly, and a beverage containing the halitosis remover of the present invention were produced by conventional methods. Their formulations are shown below. Note that the scope of the present invention is not limited by these.
(実施例3)
 下記処方に従って含そう剤を製造した。
エタノール              2.0重量%
ラクチトール            10.0
香料                 1.0
水                  残      
                 100.0
(Example 3)
A mouthwash was prepared according to the following formulation.
Ethanol 2.0% by weight
Lactitol 10.0
Fragrance 1.0
Water remaining
100.0
(実施例4)
 下記処方に従って練り歯磨きを製造した。
炭酸カルシウム           40.0重量%
グリセリン             10.0
マルチトール            20.0
カルボオキシメチルセルロース     2.0
ラルリル硫酸ナトリウム        2.0
香料                 1.0
サッカリン              0.1
クロルヘキシジン           0.01 
水                  残      
                 100.0
Example 4
A toothpaste was produced according to the following formulation.
Calcium carbonate 40.0% by weight
Glycerin 10.0
Maltitol 20.0
Carboxymethylcellulose 2.0
Sodium ralyl sulfate 2.0
Fragrance 1.0
Saccharin 0.1
Chlorhexidine 0.01
Water remaining
100.0
(実施例5)
 下記処方に従ってマウススプレーを製造した。
エタノール             10.0重量%
グリセリン              5.0
ラクチトール            10.0
マルチトール            10.0
香料                 0.05
着色料                0.001
水                  残      
                 100.0
(Example 5)
A mouse spray was produced according to the following formulation.
Ethanol 10.0% by weight
Glycerin 5.0
Lactitol 10.0
Maltitol 10.0
Fragrance 0.05
Coloring 0.001
Water remaining
100.0
(実施例6)
 下記処方に従ってトローチを製造した。
マルチトール            72.3重量%
キシリトール            20.0
アラビアガム             6.0
香料                 1.0
モノフルオロリン酸ナトリウム     0.7   
                 100.0
(Example 6)
A lozenge was produced according to the following formulation.
Maltitol 72.3 wt%
Xylitol 20.0
Gum arabic 6.0
Fragrance 1.0
Sodium monofluorophosphate 0.7
100.0
(実施例7)
 下記処方に従ってチューインガムを製造した。
ガムベース            20.0重量%
マルチトール           45.0
ラクチトール           33.0    
香料                2.0      
                 100.0
(Example 7)
Chewing gum was manufactured according to the following formulation.
Gum base 20.0% by weight
Maltitol 45.0
Lactitol 33.0
Fragrance 2.0
100.0
(実施例8)
 下記処方に従ってキャンディを製造した。
マルチトール          50.0重量%
還元水あめ           34.0
クエン酸             2.0
香料               0.2
水                残      
                 100.0
(Example 8)
Candy was manufactured according to the following prescription.
Maltitol 50.0% by weight
Reduced water candy 34.0
Citric acid 2.0
Fragrance 0.2
Water remaining
100.0
(実施例9)
 下記処方に従って錠菓を製造した。
マルチトール          76.1重量%
ラクチトール          19.0
ショ糖脂肪酸エステル       0.2
香料               0.2
水                4.5      
                 100.0
Example 9
Tablet confectionery was produced according to the following prescription.
Maltitol 76.1% by weight
Lactitol 19.0
Sucrose fatty acid ester 0.2
Fragrance 0.2
Water 4.5
100.0
(実施例10)
 下記処方に従ってグミゼリーを製造した。
ゼラチン            60.0重量%
還元水あめ           21.40
マルチトール          11.5
植物油脂             4.5
リンゴ酸             2.0
香料               0.5     
                 100.0
(Example 10)
Gummy jelly was manufactured according to the following prescription.
Gelatin 60.0% by weight
Reduced water candy 21.40
Maltitol 11.5
Vegetable oil 4.5
Malic acid 2.0
Fragrance 0.5
100.0
(実施例11)
 下記処方に従って飲料を製造した。
オレンジ果汁          30.0重量%
ラクチトール          15.0
クエン酸             0.1
ビタミンC             0.04
香料               0.1
水                残      
                 100.0
(Example 11)
A beverage was produced according to the following formulation.
Orange juice 30.0% by weight
Lactitol 15.0
Citric acid 0.1
Vitamin C 0.04
Fragrance 0.1
Water remaining
100.0
 本発明の糖アルコールを配合した口臭除去剤は、ガム、キャンディ、錠菓等への適用が可能であり、さらに口臭除去特定保健用食品への適用が可能である。 The bad breath remover containing the sugar alcohol of the present invention can be applied to gums, candy, tablet confectionery, etc., and can also be applied to bad breath removal specific health foods.
 この出願は2009年7月14日に出願された日本国特許出願第2009-165556号からの優先権を主張するものであり、その内容を引用してこの出願の一部とするものである。

 
This application claims priority from Japanese Patent Application No. 2009-165556 filed on Jul. 14, 2009, the contents of which are incorporated herein by reference.

Claims (11)

  1.  糖アルコールを有効成分とする口臭除去剤 Bad breath remover containing sugar alcohol as an active ingredient
  2.  前記糖アルコールが、ラクチトールである請求項1に記載の口臭除去剤。 The bad breath removing agent according to claim 1, wherein the sugar alcohol is lactitol.
  3.  糖アルコールを有効成分とする口臭除去剤からなる、含そう剤、練り歯磨き剤、吸入剤、トローチ剤。 An oral repellent, toothpaste, inhalant, and lozenge consisting of a bad breath remover containing sugar alcohol as an active ingredient.
  4.  前記糖アルコールが、ラクチトールである請求項3に記載の含そう剤、練り歯磨き剤、吸入剤、トローチ剤。 The mouthwash, toothpaste, inhalant, and lozenge according to claim 3, wherein the sugar alcohol is lactitol.
  5.  糖アルコールを有効成分とする口臭除去剤からなる食品。 Food made of bad breath remover containing sugar alcohol as an active ingredient.
  6.  前記糖アルコールが、ラクチトールである請求項5に記載の食品。 The food according to claim 5, wherein the sugar alcohol is lactitol.
  7.  糖アルコールを有効成分とするメチオニンおよびシステイン代謝経路阻害による揮発性硫黄化合物の産生抑制剤。 A volatile sulfur compound production inhibitor that inhibits methionine and cysteine metabolic pathways with sugar alcohol as an active ingredient.
  8.  前記糖アルコールが、ラクチトール、マルチトールである請求項7に記載の揮発性硫黄化合物の産生抑制剤。 The volatile sulfur compound production inhibitor according to claim 7, wherein the sugar alcohol is lactitol or maltitol.
  9.  糖アルコールを有効成分とするメチオニンおよびシステイン代謝経路阻害による揮発性硫黄化合物の産生抑制剤からなる、含そう剤、練り歯磨き剤、吸入剤、トローチ剤。 A mouthwash, a toothpaste, an inhalant, and a lozenge comprising a methionine and cysteine metabolic pathway inhibitor that inhibits sugar alcohol as an active ingredient.
  10.  前記糖アルコールが、ラクチトール、マルチトールである請求項9に記載の含そう剤、練り歯磨き剤、吸入剤、トローチ剤。 10. The mouthwash, toothpaste, inhalant, and lozenge according to claim 9, wherein the sugar alcohol is lactitol or maltitol.
  11.  糖アルコールを有効成分とするメチオニンおよびシステイン代謝経路阻害による揮発性硫黄化合物の産生抑制剤からなる食品。
     

     
    A food comprising an inhibitor of production of volatile sulfur compounds by inhibiting methionine and cysteine metabolic pathways containing sugar alcohol as an active ingredient.


PCT/JP2010/004531 2009-07-14 2010-07-13 Bad breath-removing agent WO2011007552A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010800297111A CN102470114A (en) 2009-07-14 2010-07-13 Bad breath-removing agent

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009165556A JP2011020936A (en) 2009-07-14 2009-07-14 Foul breath remover
JP2009-165556 2009-07-14

Publications (1)

Publication Number Publication Date
WO2011007552A1 true WO2011007552A1 (en) 2011-01-20

Family

ID=43449162

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2010/004531 WO2011007552A1 (en) 2009-07-14 2010-07-13 Bad breath-removing agent

Country Status (5)

Country Link
JP (1) JP2011020936A (en)
KR (1) KR20120042969A (en)
CN (2) CN103690385A (en)
TW (1) TW201116272A (en)
WO (1) WO2011007552A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019135951A (en) * 2018-02-08 2019-08-22 株式会社マンダム Screening method of halitosis inhibiting component

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6371336B2 (en) * 2015-06-17 2018-08-08 花王株式会社 Odor suppressor for polysulfide compounds
CN111373463A (en) * 2017-11-16 2020-07-03 宝洁公司 Product demonstration device and method thereof

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH048251A (en) * 1990-04-26 1992-01-13 Mitsui Sugar Co Ltd Chewing gum containing sweetnees-keeping coating sugars and its preparation
JPH09252723A (en) * 1996-01-18 1997-09-30 Lotte Co Ltd New milk and milk powder freed of lactose, food and drink containing the same and production of milk and milk powder freed of lactose
US6071500A (en) * 1999-01-19 2000-06-06 Thistle; Robert H. Breath spray with tooth decay and halitosis prevention characteristics
US20020132000A1 (en) * 2001-01-12 2002-09-19 Marie-Helene Saniez Sweet with a rough texture intended for the treatment of halitosis
JP2003160458A (en) * 2001-11-22 2003-06-03 Kansai Koso Kk Composition for oral cavity
WO2003090704A1 (en) * 2002-04-23 2003-11-06 Ezaki Glico Co., Ltd. Foods having effect of eliminating bad breath
JP2004203872A (en) * 2002-12-12 2004-07-22 Kao Corp Bad breath ingredient-eliminating composition, composition for oral cavity containing the same, chewing-gum, and oral cavity-refreshing confectionery
JP2006325455A (en) * 2005-05-25 2006-12-07 Kao Corp Chewing gum
JP2007185191A (en) * 2006-01-13 2007-07-26 Lotte Confectionery Co Ltd Semi-transparent shell-like confectionery composition
JP2008142077A (en) * 2006-12-11 2008-06-26 Lotte Confectionery Co Ltd Method for producing confectionary topped with flaky nuts
JP2009500399A (en) * 2005-07-08 2009-01-08 エル・ジー ハウスホールド アンド ヘルスケア リミティッド Bad breath removal agent for phase transition
JP2009286749A (en) * 2008-05-30 2009-12-10 Kanro Kk Solid material for oral cavity hygiene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1146863A (en) * 1994-06-08 1997-04-09 王昌志 Method for producing sweetmeat for refreshing mouth
TW200804345A (en) * 2005-08-30 2008-01-16 Novartis Ag Substituted benzimidazoles and methods of preparation
CN101124992A (en) * 2007-09-07 2008-02-20 王建林 'Jinsuoyinkai' health-care sugar and production technology thereof

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH048251A (en) * 1990-04-26 1992-01-13 Mitsui Sugar Co Ltd Chewing gum containing sweetnees-keeping coating sugars and its preparation
JPH09252723A (en) * 1996-01-18 1997-09-30 Lotte Co Ltd New milk and milk powder freed of lactose, food and drink containing the same and production of milk and milk powder freed of lactose
US6071500A (en) * 1999-01-19 2000-06-06 Thistle; Robert H. Breath spray with tooth decay and halitosis prevention characteristics
US20020132000A1 (en) * 2001-01-12 2002-09-19 Marie-Helene Saniez Sweet with a rough texture intended for the treatment of halitosis
JP2003160458A (en) * 2001-11-22 2003-06-03 Kansai Koso Kk Composition for oral cavity
WO2003090704A1 (en) * 2002-04-23 2003-11-06 Ezaki Glico Co., Ltd. Foods having effect of eliminating bad breath
JP2004203872A (en) * 2002-12-12 2004-07-22 Kao Corp Bad breath ingredient-eliminating composition, composition for oral cavity containing the same, chewing-gum, and oral cavity-refreshing confectionery
JP2006325455A (en) * 2005-05-25 2006-12-07 Kao Corp Chewing gum
JP2009500399A (en) * 2005-07-08 2009-01-08 エル・ジー ハウスホールド アンド ヘルスケア リミティッド Bad breath removal agent for phase transition
JP2007185191A (en) * 2006-01-13 2007-07-26 Lotte Confectionery Co Ltd Semi-transparent shell-like confectionery composition
JP2008142077A (en) * 2006-12-11 2008-06-26 Lotte Confectionery Co Ltd Method for producing confectionary topped with flaky nuts
JP2009286749A (en) * 2008-05-30 2009-12-10 Kanro Kk Solid material for oral cavity hygiene

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EI HASHINO ET AL.: "Erythritol wa Shishubyogensei Saikin no Kihatsusei Ryukabutsu Sansei o Yokusei suru", JOURNAL OF DENTAL HEALTH, vol. 59, no. 5, 30 October 2009 (2009-10-30), pages 608 - 609 + P12 *
YUJI KODAMA ET AL.: "Kihatsusei Io Kagobutsu no Sansei ni Oyobosu To Alcohol no Eikyo", THE 56TH PROCEEDINGS OF JAPANESE SOCIETY OF FOOD SCIENCE AND TECHNOLOGY, 10 September 2009 (2009-09-10), pages 137 + 3FP11 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019135951A (en) * 2018-02-08 2019-08-22 株式会社マンダム Screening method of halitosis inhibiting component
JP6989742B2 (en) 2018-02-08 2022-01-12 株式会社マンダム Screening method for halitosis-suppressing ingredients

Also Published As

Publication number Publication date
CN102470114A (en) 2012-05-23
JP2011020936A (en) 2011-02-03
KR20120042969A (en) 2012-05-03
CN103690385A (en) 2014-04-02
TW201116272A (en) 2011-05-16

Similar Documents

Publication Publication Date Title
RU2125440C1 (en) Nonalcoholic antibacterial composition for mouth rinsing (variants), method of suppression of mouth cavity microorganisms (variants) and a method of elimination of mouth unpleasant odor (variants)
US20090252690A1 (en) Flavoured Mouth Wash Composition
US20090269288A1 (en) Black pearl toothpaste
RU2504368C2 (en) SOLID CHEWING COMPOSITION AND METHOD OF INHIBITING Streptococcus mutans DEVELOPMENT
EP3164107A2 (en) Lactone-containing compositions for malodor elimination
CN103717225A (en) Compositions containing zinc salts and isothiocyanates for reduction of oral volatile sulfur compounds (vscs)
JPH07316064A (en) Suppressor for causative of periodontal disease or caries and composition for oral cavity and food containing the same
KR102288921B1 (en) Composition for prevention or treatment or oral disease
WO2011007552A1 (en) Bad breath-removing agent
KR100450391B1 (en) Toothpaste Composition
KR19980013946A (en) Oral composition of liquid type
JP6249438B2 (en) Oral hygiene improving active composition
JP6600124B2 (en) Confectionery
JP2011236144A (en) Composition for oral cavity, and foul-breath inhibitor
KR101660467B1 (en) Oral composition containing fermentative extract of lycii fructus as active ingredient
JP2016504279A (en) Oral care composition containing theaflavin extract
KR102459936B1 (en) Composition for prevention or treatment of oral disease comprising Alkannin
JP2014094968A (en) Foul breath remover
KR101834016B1 (en) Composition for use in the oral cavity
KR102452255B1 (en) Composition comprising deacetyl asperulosidic acid and/or asperulosidic acid as active ingredient for prevention or treatment of oral disease
CN114010530B (en) Composition for oral care and application thereof
KR102626864B1 (en) Composition for prevention or treatment of oral disease comprising Shikonin
KR20180055519A (en) Composition for prevention or treatment of oral disease comprising salvianolic acid A
KR102670487B1 (en) Composition for prevention or treatment of oral disease comprising cynarin
KR102665306B1 (en) Composition for prevention or treatment of oral disease comprising forsythoside B

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080029711.1

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10799616

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20127003727

Country of ref document: KR

Kind code of ref document: A

122 Ep: pct application non-entry in european phase

Ref document number: 10799616

Country of ref document: EP

Kind code of ref document: A1